Company Intelligence Profile
Granules India Limited
Granules India Limited is a Hyderabad-based pharmaceutical maker that produces APIs, formulation intermediates and finished dosages as a CDMO.
CIN: L24110TG1991PLC012471Active, CompliantTelangana
Last updated 28 October 2026
AI OverviewGenerated from public records
Granules India Limited is a pharmaceutical manufacturer based in Hyderabad, Telangana. It makes APIs, formulation intermediates and finished dosages and works as a CDMO. The company was incorporated on 18 March 1991 and is listed on BSE and NSE. In FY2024-25 it reported revenue of ₹4,482 Cr and net profit of ₹502 Cr.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
See what AICA knows about Granules India
Deeper analysis, financial signals and peer comparisons.
Company Identity
| Registered name | Granules India Limited |
|---|---|
| CIN | L24110TG1991PLC012471 |
| Status | Active, Compliant |
| Listing | 532482, NSE: GRANULES (listed public limited company) |
| Incorporated | 18 March 1991 |
| ROC | Telangana |
| Sector (NIC) | Pharma & Life Sciences (NIC 24110) |
| Registered address | 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, K.V. Rangareddy, Serilingampally, Telangana, India, 500084 |
| Authorized capital | ₹50.5 Cr |
| Paid-up capital | ₹24.3 Cr vs ₹24.78 Cr — minor discrepancy, likely different as-of dates; report both |
Business Overview
- Granules India Limited makes Active Pharmaceutical Ingredients, Pharmaceutical Formulation Intermediates and Finished Dosages.
- It works as a CDMO and is based in Hyderabad, India.
- Finished Dosages bring in about 74% of FY26 revenue.
- The company serves 300+ customers in 80+ countries from 10 manufacturing facilities.
- It was incorporated on 18 March 1991.
Directors
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Krishna Prasad Chigurupati | 00020180 | Managing Director & Chairman | - |
| Harsha Chigurupati | 01606477 | Whole-time Director | - |
| Umadevi Chigurupati | 00737689 | Whole-time Director | - |
| Priyanka Chigurupati | 01793431 | Director | - |
| Arun Sawhney | 01929668 | Director | - |
| Basava Sankar Rao Kolli | 05167550 | Director | - |
| Palepu Sucharita Rao | 07807717 | Director | - |
| Saumen Chakraborty | 06471520 | Director | - |
| Sethurathnam Ravi | 00009790 | Additional Director | - |
| Rajiv Pritidas Kakodkar | 01519590 | Additional Director | - |
| Kapil Mehan | 01215092 | Director | - |
Financials
FY2024-25
- Revenue ₹4,482 Cr
- EBITDA ₹948 Cr
- Net profit ₹502 Cr
- Net worth ₹3,715 Cr
- Borrowings ₹1,455 Cr
Charges & Borrowings
| Open charges | ₹905 Cr |
|---|---|
| Satisfied charges | ₹2,314.91 Cr |
Legal & Compliance
- Incyte Holdings Corporation vs Granules India Limited - Delhi High Court, 2024, civil and IP dispute
- Granules India Ltd vs Union of India - Telangana High Court, 2024
- Granules India Ltd vs Union of India - Supreme Court, AIR 2020 SC 594, customs and excise appeal
- Granules India Limited vs Commissioner of Central Excise - CESTAT, 2015
- Granules India Ltd vs Union of India - Delhi High Court, 2015, WP(C) 3320/2015
Competitors
Divi's Laboratories
API and CDMO peer
Aurobindo Pharma
diversified formulations and API
Laurus Labs
CDMO and API peer
Dr. Reddy's Laboratories
diversified pharma
Suven Pharmaceuticals
CDMO peer
Neuland Laboratories
API and CDMO peer
Frequently Asked Questions
What does Granules India Limited do?
Granules India Limited makes Active Pharmaceutical Ingredients, Pharmaceutical Formulation Intermediates and Finished Dosages. It works as a CDMO and serves customers in over 80 countries.
When was Granules India Limited incorporated?
Granules India Limited was incorporated on 18 March 1991. It is a listed public limited company registered with the RoC in Hyderabad, Telangana.
What is the CIN of Granules India Limited?
The CIN of Granules India Limited is L24110TG1991PLC012471.
Where is Granules India Limited registered?
The registered office is at 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Serilingampally, Telangana, 500084.
Who are the directors of Granules India Limited?
Krishna Prasad Chigurupati is Managing Director and Chairman. Harsha Chigurupati and Umadevi Chigurupati are Whole-time Directors. Other directors include Priyanka Chigurupati, Arun Sawhney and Kapil Mehan.
Recur Market
Which lenders fit a company like Granules India Limited?
Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.
Similar Pharma & Life Sciences companies
- DIVINECARE PHARMA PRIVATE LIMITEDDIVINECARE PHARMA PRIVATE LIMITED is a private company in Bengaluru, classed as a pharmaceutical manufacturer, incorporated in June 2020.
- ICON Clinical Research India Private LimitedICON Clinical Research India is the Indian arm of global research firm ICON plc, running clinical trials for drug, biotech and medical-device companies.
- Scitus Pharma Services Private LimitedScitus Pharma Services Private Limited is a Chennai-based private company classified under scientific research and development services.
- VIMAL DRUGS PRIVATE LIMITEDVIMAL DRUGS PRIVATE LIMITED makes bulk drugs and intermediates from its base in Hyderabad, Telangana.
- SIA PHARMA PRIVATE LIMITEDSIA PHARMA PRIVATE LIMITED is a pharmaceutical company based in Sonipat, Haryana, incorporated in 2008.
- Fermedicius Labs Private LimitedFermedicius Labs contract-manufactures nutraceuticals, herbal products and wellness supplements, with private-label options, from Bengaluru.
More on Recur Club
Recently added companies
Lenders on Recur Club
Explore on Recur Club
Revenue-Based FinancingRepay as a share of monthly revenueWorking Capital LoansCollateral-light capital for operationsSecured Term LoansLarger, longer-tenure debtCheck Your EligibilityEstimate funding in minutesCompany SearchExplore more company profilesFinance CalculatorsFree tools for founders & finance teams
More from Recur Club
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.